
Number of publications published per year by Dhar, Dipok K.. (Source : PubMed)

Distribution of publications types for Dhar, Dipok K.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis.
Clin. Gastroenterol. Hepatol.
2009;7;10

Kartagener's Syndrome.
Mymensingh Med J
2009;18;1

Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats.
J. Gastroenterol. Hepatol.
2008;23;6
Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer.
Eur. J. Cancer
2007;43;9

FR-167653, a selective p38 MAPK inhibitor, exerts salutary effect on liver cirrhosis through downregulation of Runx2.
Lab. Invest.
2007;87;6
Differential expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3 worsens patient prognosis.
Oncology
2007;73;5-6
Prognosis of patients with gastric carcinoma treated in remote island hospitals in Japan: a multivariable analysis.
Anticancer Res.
2006;26;5B
Tetracycline analogues (doxycycline and COL-3) induce caspase-dependent and -independent apoptosis in human colon cancer cells.
Int. J. Cancer
2006;118;5
Expression of hypoxia inducible factor-1alpha during liver regeneration induced by partial hepatectomy in rats.
Liver Int.
2005;25;5
Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis.
Clin. Cancer Res.
2005;11;18
[ See timeline ] [ See all publications ]
means that Dhar, Dipok K. has 21 papers cited a least 21 times - methodology
Department of Digestive and General Surgery, Faculty of Medicine, Shimane University, Enyacho, Izumo, Japan.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.